SYCREST

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Japan, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug SYCREST contains one active pharmaceutical ingredient (API):

1 Asenapine UNII CU9463U2E2 - ASENAPINE MALEATE

The mechanism of action of asenapine is not fully understood. However, based on its receptor pharmacology, it is proposed that the efficacy of asenapine is mediated through a combination of antagonist activity at D2 and 5-HT2A receptors. Actions at other receptors e.g. 5-HT1A, 5-HT1B, 5-HT2C, 5-HT6, 5-HT7, D3, and a2-adrenergic receptors, may also contribute to the clinical effects of asenapine. Read about Asenapine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SYCREST Sublingual tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AH05	Asenapine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1491296, 1491308, 1491319, 1491353, 1491364, 1491375
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 10640002, 10640005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 144035, 444041, 459766, 513474
Country: FR	Base de données publique des médicaments	Identifier(s): 61455009, 65697814
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 194964, 194967
Country: IE	Health Products Regulatory Authority	Identifier(s): 31008, 31009
Country: IT	Agenzia del Farmaco	Identifier(s): 040761013, 040761025, 040761037, 040761049, 040761052, 040761064
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179056F1021, 1179056F2028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1056399, 1056400, 1056401, 1056402, 1056403, 1056404
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100229900, 100229917
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W56547001, W56547002, W56547003, W56548001, W56548002, W56548003